Group One Trading’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,000
Closed -$6.77M 8112
2025
Q4
$6.77M Buy
10,000
+9,500
+1,900% +$6.47M 0.01% 1241
2025
Q3
$319K Buy
+500
New +$303K ﹤0.01% 4158
2024
Q2
Sell
-1,400
Closed -$756K 7069
2024
Q1
$756K Buy
1,400
+800
+133% +$437K ﹤0.01% 2338
2023
Q4
$333K Buy
600
+200
+50% +$93.9K ﹤0.01% 3418
2023
Q3
$175K Buy
+400
New +$199K ﹤0.01% 3914
2023
Q2
Sell
-30,600
Closed -$15.3M 7908
2023
Q1
$15.3M Hold
30,600
0.06% 291
2022
Q4
$12.5M Buy
+30,600
New +$11.9M 0.03% 609
2022
Q3
Sell
-200
Closed -$70K 7822
2022
Q2
$70K Sell
200
-51,800
-100% -$21.1M ﹤0.01% 5286
2022
Q1
$28.4M Sell
52,000
-1,300
-2% -$684K 0.03% 453
2021
Q4
$35.1M Buy
53,300
+50,500
+1,804% +$31.7M 0.03% 422
2021
Q3
$1.74M Sell
2,800
-1,400
-33% -$941K ﹤0.01% 2808
2021
Q2
$2.65M Buy
4,200
+2,700
+180% +$1.49M ﹤0.01% 2349
2021
Q1
$734K Buy
+1,500
New +$752K ﹤0.01% 3592

Other funds holding IDXX

Group One Trading's IDXX Position: Q1 2026 in Review

Group One Trading sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 6,212 shares — an estimated $4.2M sold.

Group One Trading first reported a position in IDXX in Q2 2017 and held it in 9 quarters. The position peaked at $6.08M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Group One Trading reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 6,212 Idexx Laboratories shares in Q1 2026, an estimated $4.2M.
  • Group One Trading first reported a position in Idexx Laboratories in Q2 2017 and held it in 9 quarters.
  • Group One Trading's Idexx Laboratories position peaked at $6.08M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.